Literature DB >> 14530774

Drotrecogin alfa (activated) administration: too many subgroups.

J Carlet.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14530774     DOI： 10.1097/01.CCM.0000089929.73924.4C

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

1.  Looking at subgroups in an inhomogeneous population does not make these subgroups more homogeneous.

Authors:  Jean Carlet
Journal:  Intensive Care Med       Date:  2004-05-13       Impact factor: 17.440

Review 2.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

Review 3.  T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression.

Authors:  Stephanie A Condotta; Javier Cabrera-Perez; Vladimir P Badovinac; Thomas S Griffith
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  Drotrecogin alfa (activated): down and not out, but not really in either.

Authors:  Jan O Friedrich; Neill K J Adhikari; Maureen O Meade
Journal:  Crit Care       Date:  2006       Impact factor: 9.097
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.